Pandion Therapeutics Inc (PAND)

60.05  +0.13 (+0.22%)

After market: 60.05 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Pandion Therapeutics Inc

NASDAQ:PAND (3/31/2021, 7:12:53 PM)

After market: 60.05 0 (0%)

60.05

+0.13 (+0.22%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap1.77B
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

PAND Daily chart

Company Profile

Pandion Therapeutics Inc. is a biotechnology company. It focuses on developing modular proteins, antibodies and bispecifics for the treatment of autoimmune and inflammatory diseases. Pandion Therapeutics Inc. is based in North Cambridge, United States.

Company Info

Pandion Therapeutics Inc

134 COOLIDGE AVENUE 2ND FLOOR

WATERTOWN MA 02472

P: 617-393-5925

CEO: Rahul Kakkar

PAND Twits

Here you can normally see the latest stock twits on PAND, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example